Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Treasury Shares: 2017-2019

Historic Treasury Shares for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $765,151.

  • EyePoint Pharmaceuticals' Treasury Shares rose 21.62% to $765,151 in Q1 2019 from the same period last year, while for Mar 2019 it was $765,151, marking a year-over-year increase of 21.62%. This contributed to the annual value of $898,129 for FY2018, which is 28.30% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Treasury Shares of $765,151 as of Q1 2019, which was up 29.64% from $590,213 recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Treasury Shares high stood at $898,129 for Q2 2018, and its period low was $590,213 during Q4 2018.
  • In the last 3 years, EyePoint Pharmaceuticals' Treasury Shares had a median value of $700,000 in 2017 and averaged $736,079.
  • The largest annual percentage gain for EyePoint Pharmaceuticals' Treasury Shares in the last 5 years was 28.30% (2018), contrasted with its biggest fall of 12.45% (2018).
  • EyePoint Pharmaceuticals' Treasury Shares (Quarterly) stood at $674,116 in 2017, then declined by 12.45% to $590,213 in 2018, then climbed by 21.62% to $765,151 in 2019.
  • Its Treasury Shares was $765,151 in Q1 2019, compared to $590,213 in Q4 2018 and $895,829 in Q3 2018.